Terms: = Breast cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300
394 results:
1. Upregulation of p300 in paclitaxel-resistant TNBC: implications for cell proliferation via the PCK1/AMPK axis.
Zhao PW; Cui JX; Wang XM
Pharmacogenomics J; 2024 Feb; 24(2):5. PubMed ID: 38378770
[TBL] [Abstract] [Full Text] [Related]
2. Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/p300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells.
Dash SR; Das C; Das B; Jena AB; Paul S; Sinha S; Tripathy J; Kundu CN
Nanomedicine (Lond); 2024 Mar; 19(7):581-596. PubMed ID: 38293827
[No Abstract] [Full Text] [Related]
3. Novel berberine derivatives as p300 histone acetyltransferase inhibitors in combination treatment for breast cancer.
Lai R; Lin Z; Yang C; Hai L; Yang Z; Guo L; Nie R; Wu Y
Eur J Med Chem; 2024 Feb; 266():116116. PubMed ID: 38215590
[TBL] [Abstract] [Full Text] [Related]
4. Vitamin D inhibits tamoxifen-induced non-alcoholic fatty liver disease through a nonclassical estrogen receptor/liver X receptor pathway.
Wu M; Wang J; Zhou W; Wang M; Hu C; Zhou M; Jiao K; Li Z
Chem Biol Interact; 2024 Feb; 389():110865. PubMed ID: 38191086
[TBL] [Abstract] [Full Text] [Related]
5. Roles and signaling pathways of CITED1 in tumors: overview and novel insights.
Chen W; Jiang J; Gao J; Wang G; Wang R; Lv J; Ben J
J Int Med Res; 2024 Jan; 52(1):3000605231220890. PubMed ID: 38190845
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of CREB Binding and Function with a Dual-Targeting Ligand.
Liu Y; Joy ST; Henley MJ; Croskey A; Yates JA; Merajver SD; Mapp AK
Biochemistry; 2024 Jan; 63(1):1-8. PubMed ID: 38086054
[TBL] [Abstract] [Full Text] [Related]
7. I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs.
Strachowska M; Gronkowska K; Sobczak M; Grodzicka M; Michlewska S; Kołacz K; Sarkar T; Korszun J; Ionov M; Robaszkiewicz A
Biomed Pharmacother; 2023 Dec; 168():115798. PubMed ID: 37913733
[TBL] [Abstract] [Full Text] [Related]
8. BRD9-mediated control of the TGF-β/Activin/Nodal pathway regulates self-renewal and differentiation of human embryonic stem cells and progression of cancer cells.
Wang X; Song C; Ye Y; Gu Y; Li X; Chen P; Leng D; Xiao J; Wu H; Xie S; Liu W; Zhao Q; Chen D; Chen X; Wu Q; Chen G; Zhang W
Nucleic Acids Res; 2023 Nov; 51(21):11634-11651. PubMed ID: 37870468
[TBL] [Abstract] [Full Text] [Related]
9. Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer.
Jiang C; Zhu Y; Chen H; Lin J; Xie R; Li W; Xue J; Chen L; Chen X; Xu S
Cell Death Dis; 2023 Oct; 14(10):653. PubMed ID: 37803002
[TBL] [Abstract] [Full Text] [Related]
10. Mechanisms of breast cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
Semenza GL
Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
[TBL] [Abstract] [Full Text] [Related]
11. ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression.
Zhang Y; Wang W; Min J; Liu S; Wang Q; Wang Y; Xiao Y; Li X; Zhou Z; Liu S
Cell Rep; 2023 Jun; 42(6):112654. PubMed ID: 37342906
[TBL] [Abstract] [Full Text] [Related]
12. breast cancer Therapeutics and Hippo Signaling Pathway: Novel MicroRNA-Gene-Protein Interaction Networks.
Gupta SRR; Nagar G; Mittal P; Rana S; Singh H; Singh R; Singh A; Singh IK
OMICS; 2023 Jun; 27(6):273-280. PubMed ID: 37311160
[TBL] [Abstract] [Full Text] [Related]
13. Combination Curcuma longa and Phyllanthus niruri Extract Potentiate Antiproliferative in Triple Negative breast cancer MDAMB-231 Cells.
Hermansyah D; Anggia Paramita D; Paramita DA; Amalina ND
Asian Pac J Cancer Prev; 2023 May; 24(5):1495-1505. PubMed ID: 37247268
[TBL] [Abstract] [Full Text] [Related]
14. Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes.
Møller NB; Boonen DS; Feldner ES; Hao Q; Larsen M; Lænkholm AV; Borg Å; Kvist A; Törngren T; Jensen UB; Boonen SE; Thomassen M; Terkelsen T
Sci Rep; 2023 May; 13(1):8536. PubMed ID: 37237042
[TBL] [Abstract] [Full Text] [Related]
15. KLF12 promotes the proliferation of breast cancer cells by reducing the transcription of p21 in a p53-dependent and p53-independent manner.
Li Y; Li S; Shi X; Xin Z; Yang Y; Zhao B; Li Y; Lv L; Ren P; Wu H
Cell Death Dis; 2023 May; 14(5):313. PubMed ID: 37156774
[TBL] [Abstract] [Full Text] [Related]
16. Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer.
Xia K; Li S; Yang Y; Shi X; Zhao B; Lv L; Xin Z; Kang J; Ren P; Wu H
Cell Death Dis; 2023 Apr; 14(4):250. PubMed ID: 37024472
[TBL] [Abstract] [Full Text] [Related]
17. RP11-367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial-mesenchymal transition.
Shao IH; Peng PH; Wu HH; Chen JL; Lai JC; Chang JS; Wu HT; Wu KJ; Pang ST; Hsu KW
Cancer Med; 2023 Apr; 12(8):9788-9801. PubMed ID: 36847128
[TBL] [Abstract] [Full Text] [Related]
18. FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive breast cancer.
Caligiuri M; Williams GL; Castro J; Battalagine L; Wilker E; Yao L; Schiller S; Toms A; Li P; Pardo E; Graves B; Azofeifa J; Chicas A; Herbertz T; Lai M; Basken J; Wood KW; Xu Q; Guichard SM
Target Oncol; 2023 Mar; 18(2):269-285. PubMed ID: 36826464
[TBL] [Abstract] [Full Text] [Related]
19. Tea domain transcription factor TEAD4 mitigates TGF-β signaling and hepatocellular carcinoma progression independently of YAP.
Luo W; Li Y; Zeng Y; Li Y; Cheng M; Zhang C; Li F; Wu Y; Huang C; Yang X; Kremerskothen J; Zhang J; Zhang C; Tu S; Li Z; Luo Z; Lin Z; Yan X
J Mol Cell Biol; 2023 Jun; 15(2):. PubMed ID: 36806855
[TBL] [Abstract] [Full Text] [Related]
20. The activation of ep300 by F11R leads to EMT and acts as a prognostic factor in triple-negative breast cancers.
Li CH; Fang CY; Chan MH; Lu PJ; Ger LP; Chu JS; Chang YC; Chen CL; Hsiao M
J Pathol Clin Res; 2023 May; 9(3):165-181. PubMed ID: 36782375
[TBL] [Abstract] [Full Text] [Related]
[Next]
